Market Overview:
The global glass vaccine vial market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for preventive and therapeutic vaccines, rising prevalence of infectious diseases, and technological advancements in the vaccine industry. Based on type, the global glass vaccine vial market is segmented into molded glass vials and tubular glass vials. The molded glass vial segment is expected to grow at a higher CAGR than the tubular glass vial segment during the forecast period. This can be attributed to its properties such as high strength-to-weight ratio, superior aesthetics, and ease of manufacturing. Based on application, the global Glass Vaccine Vial Market is divided into preventive vaccines and therapeutic vaccines segments.
Product Definition:
A glass vaccine vial is a container used to store vaccines. The importance of glass vaccine vials is that they are sterile and can be stored at room temperature, which makes them ideal for use in developing countries.
Molded Glass Vial:
Molded glass vial is a type of glass container that is used to store various medicines and vaccines. It has a uniform shape and can be used for long term storage purpose. The most common types of molded glass vials are vaccine vials, insulin ampoules, pain relief tablets/capsules, cough syrup bottles among others.
Tubular Glass Vial:
Tubular glass vial is a type of glass container that is widely used to store liquid products. It has a hollow interior and can be used for the packaging of vaccines, medicines, biological samples and other liquids. The most commonly used types of tubular glass vials are straight-stem and elbow-stem. They are available in different sizes as per the volume or dose required by the product being packaged.
Application Insights:
The preventive vaccine application segment dominated the global glass vaccine vial market in 2017. This is attributed to the growing use of glass vaccines for prevention against diseases such as chickenpox, typhoid, cholera and hepatitis A & B. The therapeutic vaccine application segment is expected to witness lucrative growth over the forecast period owing to its increasing use in cancer treatment immunotherapy.
Therapeutic vaccines are used for treatment of chronic or acute diseases where patients have failed conventional therapy methods with little or no response. These therapies require a patient¢â‚¬â„¢s immune system be activated and stimulated so that it will recognize and attack cancer cells thus resulting in cure or improvement of clinical condition (1).
Regional Analysis:
North America dominated the global glass vaccine vial market in 2017. This is attributed to the presence of a large number of players in this region, which has resulted in an increased availability of various glass vials for use as a vaccine container. The U.S., which is one of the most developed nations across the globe, holds a major share within North America and globally.
The Asia Pacific region held significant potential for growth during 2018 and will continue to do so over the forecast period owing to increasing government initiatives pertaining to immunization programs against infectious diseases coupled with rising awareness about vaccines among people living in this region.
Growth Factors:
- Increasing demand for preventive healthcare services
- Rising prevalence of chronic diseases
- Technological advancements in vaccine delivery systems
- Growing awareness about the benefits of vaccination
- Government initiatives and programs to promote vaccination
Scope Of The Report
Report Attributes
Report Details
Report Title
Glass Vaccine Vial Market Research Report
By Type
Molded Glass Vial, Tubular Glass Vial
By Application
Preventive Vaccine, Therapeutic Vaccine
By Companies
Schott AG, Nippon Electric Glass, Corning, DWK Life Sciences, Richland Glass, Nipro, Pacific Vial Manufacturing, Origin Ltd, Stevanato Group, SGD Pharma, Zheng Chuan, Shandong Pharmaceutical Glass, Zheng Li, Gerresheimer, Four Stars Glass, JOTOP Glass
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Glass Vaccine Vial Market Report Segments:
The global Glass Vaccine Vial market is segmented on the basis of:
Types
Molded Glass Vial, Tubular Glass Vial
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Preventive Vaccine, Therapeutic Vaccine
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Schott AG
- Nippon Electric Glass
- Corning
- DWK Life Sciences
- Richland Glass
- Nipro
- Pacific Vial Manufacturing
- Origin Ltd
- Stevanato Group
- SGD Pharma
- Zheng Chuan
- Shandong Pharmaceutical Glass
- Zheng Li
- Gerresheimer
- Four Stars Glass
- JOTOP Glass
Highlights of The Glass Vaccine Vial Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Molded Glass Vial
- Tubular Glass Vial
- By Application:
- Preventive Vaccine
- Therapeutic Vaccine
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glass Vaccine Vial Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A glass vaccine vial is a type of medical container made from glass that is used to store vaccines. Glass vaccine vials are often preferred over other types of medical containers because they are more resistant to breakage and they do not corrode.
Some of the major players in the glass vaccine vial market are Schott AG, Nippon Electric Glass, Corning, DWK Life Sciences, Richland Glass, Nipro, Pacific Vial Manufacturing, Origin Ltd, Stevanato Group, SGD Pharma, Zheng Chuan, Shandong Pharmaceutical Glass, Zheng Li, Gerresheimer, Four Stars Glass, JOTOP Glass.
The glass vaccine vial market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Glass Vaccine Vial Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Glass Vaccine Vial Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Glass Vaccine Vial Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Glass Vaccine Vial Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Glass Vaccine Vial Market Size & Forecast, 2018-2028
4.5.1 Glass Vaccine Vial Market Size and Y-o-Y Growth
4.5.2 Glass Vaccine Vial Market Absolute $ Opportunity
Chapter 5 Global Glass Vaccine Vial Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Glass Vaccine Vial Market Size Forecast by Type
5.2.1 Molded Glass Vial
5.2.2 Tubular Glass Vial
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Glass Vaccine Vial Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Glass Vaccine Vial Market Size Forecast by Applications
6.2.1 Preventive Vaccine
6.2.2 Therapeutic Vaccine
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Glass Vaccine Vial Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Glass Vaccine Vial Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Glass Vaccine Vial Analysis and Forecast
9.1 Introduction
9.2 North America Glass Vaccine Vial Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Glass Vaccine Vial Market Size Forecast by Type
9.6.1 Molded Glass Vial
9.6.2 Tubular Glass Vial
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Glass Vaccine Vial Market Size Forecast by Applications
9.10.1 Preventive Vaccine
9.10.2 Therapeutic Vaccine
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Glass Vaccine Vial Analysis and Forecast
10.1 Introduction
10.2 Europe Glass Vaccine Vial Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Glass Vaccine Vial Market Size Forecast by Type
10.6.1 Molded Glass Vial
10.6.2 Tubular Glass Vial
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Glass Vaccine Vial Market Size Forecast by Applications
10.10.1 Preventive Vaccine
10.10.2 Therapeutic Vaccine
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Glass Vaccine Vial Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Glass Vaccine Vial Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Glass Vaccine Vial Market Size Forecast by Type
11.6.1 Molded Glass Vial
11.6.2 Tubular Glass Vial
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Glass Vaccine Vial Market Size Forecast by Applications
11.10.1 Preventive Vaccine
11.10.2 Therapeutic Vaccine
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Glass Vaccine Vial Analysis and Forecast
12.1 Introduction
12.2 Latin America Glass Vaccine Vial Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Glass Vaccine Vial Market Size Forecast by Type
12.6.1 Molded Glass Vial
12.6.2 Tubular Glass Vial
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Glass Vaccine Vial Market Size Forecast by Applications
12.10.1 Preventive Vaccine
12.10.2 Therapeutic Vaccine
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Glass Vaccine Vial Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Glass Vaccine Vial Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Glass Vaccine Vial Market Size Forecast by Type
13.6.1 Molded Glass Vial
13.6.2 Tubular Glass Vial
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Glass Vaccine Vial Market Size Forecast by Applications
13.10.1 Preventive Vaccine
13.10.2 Therapeutic Vaccine
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Glass Vaccine Vial Market: Competitive Dashboard
14.2 Global Glass Vaccine Vial Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Schott AG
14.3.2 Nippon Electric Glass
14.3.3 Corning
14.3.4 DWK Life Sciences
14.3.5 Richland Glass
14.3.6 Nipro
14.3.7 Pacific Vial Manufacturing
14.3.8 Origin Ltd
14.3.9 Stevanato Group
14.3.10 SGD Pharma
14.3.11 Zheng Chuan
14.3.12 Shandong Pharmaceutical Glass
14.3.13 Zheng Li
14.3.14 Gerresheimer
14.3.15 Four Stars Glass
14.3.16 JOTOP Glass
